Safety and Immunogenicity of Hepatitis B Vaccine Regimens in Adults With HIV-1 Reply

被引：0
|
作者：
Launay, Odile [1 ]
Carrat, Fabrice [2 ]
机构：
[1] Univ Paris 05, Paris, France
[2] Univ Paris 06, Paris, France
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2011年 / 306卷 / 02期
关键词：
D O I：
10.1001/jama.2011.944
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：156 / 157
页数：2
相关论文
共 50 条
  • [41] Safety and immunogenicity of HBAI20 Hepatitis B vaccine in naive and non-responding adults
    Lashof, A. M. O.
    Koc, O. M.
    van Loo, I. H.
    Savelkoul, P. H.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S61 - S61
  • [42] Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adults
    Van Damme, Pierre
    Minervini, Gianmaria
    Liss, Charles L.
    McCarson, Barbara
    Vesikari, Timo
    Boslego, John W.
    Bhuyan, Prakash K.
    HUMAN VACCINES, 2009, 5 (02): : 92 - 97
  • [43] Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults
    Beran, Jiri
    Hobzova, Lenka
    Wertzova, Veronika
    Kuriyakose, Sherine
    Leyssen, Maarten
    Surquin, Murielle
    Houard, Sophie
    HUMAN VACCINES, 2010, 6 (07): : 578 - 584
  • [44] SAFETY AND IMMUNOGENICITY OF AN INACTIVATED HEPATITIS A VACCINE
    WESTBLOM, TU
    GUDIPATI, S
    DEROUSSE, C
    MIDKIFF, BR
    BELSHE, RB
    CLINICAL RESEARCH, 1991, 39 (03): : A727 - A727
  • [45] Phase 1 Safety and Immunogenicity Evaluation of ADVAX, a Multigenic, DNA-Based Clade C/B′ HIV-1 Candidate Vaccine
    Vasan, Sandhya
    Schlesinger, Sarah J.
    Huang, Yaoxing
    Hurley, Arlene
    Lombardo, Angela
    Chen, Zhiwei
    Than, Soe
    Adesanya, Phumla
    Bunce, Catherine
    Boaz, Mark
    Boyle, Rosanne
    Sayeed, Eddy
    Clark, Lorna
    Dugin, Daniel
    Schmidt, Claudia
    Song, Yang
    Seamons, Laura
    Dally, Len
    Ho, Martin
    Smith, Carol
    Markowitz, Martin
    Cox, Josephine
    Gill, Dilbinder K.
    Gilmour, Jill
    Keefer, Michael C.
    Fast, Patricia
    Ho, David D.
    PLOS ONE, 2010, 5 (01):
  • [46] Immunogenicity and safety of pandemic H1N1 2009 influenza vaccine for HIV-1 patients
    Jilich, D.
    Havlickova, M.
    Vesely, D.
    Rozsypal, H.
    Jirincova, H.
    Stankova, M.
    Kyncl, J.
    Maly, M.
    Machala, L.
    ACTA VIROLOGICA, 2012, 56 (04) : 349 - 351
  • [47] Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1
    Whitaker, Jennifer A.
    Rouphael, Nadine G.
    Edupuganti, Srilatha
    Lai, Lilin
    Mulligan, Mark J.
    LANCET INFECTIOUS DISEASES, 2012, 12 (12): : 966 - 976
  • [48] Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults
    Halperin, Scott A.
    McNeil, Shelly
    Langley, Joanne M.
    Smith, Bruce
    MacKinnon-Cameron, Donna
    McCall-Sani, Robyn
    Heyward, William L.
    Martin, J. Tyler
    VACCINE, 2012, 30 (36) : 5445 - 5448
  • [49] Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
    Levy, Itzchak
    Wieder-Finesod, Anat
    Litchevsky, Vladyslav
    Biber, Asaf
    Indenbaum, Victoria
    Olmer, Liraz
    Huppert, Amit
    Mor, Orna
    Goldstein, May
    Levin, Einav Gal
    Hod, Tammy
    Cohen, Carmit
    Lustig, Yaniv
    Rahav, Galia
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (12) : 1851 - 1855
  • [50] Immunogenicity of lyophilized MVA vaccine for HIV-1 in mice model
    Zhang Zi-zhe
    Jiang Chun-lai
    Yu Xiang-hui
    Lou Chao-ping
    Zhao Dong-hai
    Wu Yong-ge
    Jin Ying-hua
    Liu Cheng-shan
    Kong Wei
    CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2007, 23 (03) : 329 - 332
12345